Zinzino News |
|
Zinzino October Revenue Rises 1% to 328.7 Million Kronor as North America Jumps 46% ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2026 Zinzino Second Quarter Revenue Rises 18 Percent to 936.8 Million Kronor Zinzino Opens Colombia as Official Market After Strong Pre-Launch Demand Zinzino First Quarter Revenue Rises 27 Percent to 922 Million Kronor Zinzino Issues Shares to Settle Sanki and Bode Pro Acquisitions For more information on Zinzino including the company's current rank in our home business index, please click here. |
Zinzino October Revenue Rises 1% to 328.7 Million Kronor as North America Jumps 46% |
Press Release | 11/4/2026 GOTHENBURG, Sweden - November 4, 2026 Zinzino reported preliminary group revenue of 328.7 million Swedish kronor for October, up 1 percent from 326.0 million kronor a year earlier, as growth in North America, South America, and Asia-Pacific offset declines across several European regions. Revenue from Zinzino's sales markets rose 1 percent to 325.1 million kronor from 323.3 million kronor. External sales at the company's Faun Pharma manufacturing unit increased 33 percent to 3.6 million kronor from 2.7 million kronor. Accumulated revenue for January through October increased 19 percent to 3,128.0 million kronor from 2,628.2 million kronor. By region in October, North America was the largest growth driver, climbing 46 percent to 72.2 million kronor from 49.5 million kronor. South America rose 87 percent to 2.8 million kronor, and Asia-Pacific increased 17 percent to 32.3 million kronor. Central Europe, the company's largest region in the month at 101.6 million kronor, was up 1 percent. European weakness weighed on the monthly comparison. The Nordics fell 20 percent to 29.4 million kronor, East Europe dropped 24 percent to 26.3 million kronor, South and West Europe declined 13 percent to 49.6 million kronor, and the Baltics fell 33 percent to 8.7 million kronor. Africa slipped 4 percent to 2.2 million kronor. On a year-to-date basis through October, North America remained the standout, up 59 percent to 672.0 million kronor. South America increased 268 percent to 35.7 million kronor, and Central Europe rose 26 percent to 951.7 million kronor. East Europe was down 13 percent, the Baltics were down 8 percent, and the Nordics were down 2 percent. Sales-market revenue for the first ten months reached 3,078.1 million kronor, up 19 percent, while Faun Pharma's external sales were up 16 percent to 49.9 million kronor. The flash report covers sales by region and does not include profit figures. Zinzino, based in Gothenburg, Sweden, is listed on Nasdaq First North Premier Growth Market and sells test-based nutrition products through direct sales distributors in more than 100 markets. |
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2026 |
Press Release | 10/5/2026 GOTHENBURG, Sweden -- October 5, 2026 Zinzino published a preliminary sales report showing group revenue for the third quarter of 2026 of 928.2 million Swedish kronor, up 18 percent from 784.1 million kronor a year earlier. Revenue from Zinzino sales markets rose 18 percent to 917.3 million kronor from 774.8 million kronor. External sales at Faun Pharma were 10.9 million kronor, up 17 percent from 9.3 million kronor. September alone brought group revenue of 317.3 million kronor, up 16 percent from 274.5 million kronor. Zinzino sales-market revenue in September was 310.9 million kronor, up 15 percent, while Faun Pharma external sales were 6.4 million kronor, up 73 percent. Accumulated revenue for January through September 2026 increased 21 percent to 2,787.1 million kronor from 2,302.2 million kronor. By region in the third quarter, North America rose 55 percent to 195.0 million kronor, South America nearly tripled to 10.1 million kronor, Asia-Pacific rose 48 percent to 95.1 million kronor and Central Europe rose 19 percent to 288.8 million kronor. East Europe declined 14 percent and the Baltics declined 13 percent, while the Nordics were down 3 percent. The flash report covers sales by region and does not include profit figures. Zinzino is listed on Nasdaq First North Premier Growth Market and sells test-based nutrition products through direct sales distributors in more than 100 markets. |
Zinzino Second Quarter Revenue Rises 18 Percent to 936.8 Million Kronor |
Press Release | 8/25/2026 GOTHENBURG, Sweden -- August 25, 2026 Zinzino reported second-quarter 2026 total revenue of 936.8 million Swedish kronor, up 18% from 794.4 million kronor a year earlier and up 23% in local currencies. EBITDA rose to 153.1 million kronor from 79.7 million kronor, with the EBITDA margin at 16.3% versus 10.0%. Gross profit was 351.3 million kronor with a 37.5% margin. Net income was 105.8 million kronor, or 2.72 kronor per share before dilution. Cash flow from operating activities was 175.8 million kronor. For the first half, revenue was 1,858.9 million kronor, up 22%, and EBITDA was 295.3 million kronor. The company said it continued to realize synergies from the ITWorks acquisition, opened Colombia as an official South American market and launched an AI-driven customer support tool. Cash and cash equivalents were 842.0 million kronor at period end. |
Zinzino Opens Colombia as Official Market After Strong Pre-Launch Demand |
Press Release | 6/11/2026 GOTHENBURG, Sweden -- June 11, 2026 Zinzino said it has officially opened Colombia as a new market on June 11, 2026, after pre-launch sales through its global webshop reached about 2 million kronor a month. CEO Dag Bergheim Pettersen called Colombia one of Latin America's most attractive direct-selling markets and said the company is entering from a position of strength after proven demand for its products and business opportunity. Zinzino cited Colombia's population of more than 53 million and industry estimates of more than 2 billion dollars in annual direct-selling retail sales and more than 2.6 million independent distributors. The launch follows Peru's February opening as Zinzino's first official South American market and continues the company's regional expansion alongside integration of recent acquisitions. |
Zinzino First Quarter Revenue Rises 27 Percent to 922 Million Kronor |
Press Release | 5/22/2026 GOTHENBURG, Sweden -- May 22, 2026 Zinzino reported first-quarter 2026 revenue of 922.1 million kronor, up 27% from 723.7 million kronor a year earlier, or 37% in local currencies, and said EBITDA rose to 142.3 million kronor with a 15.4% margin. Gross profit was 341.5 million kronor, and net profit was 104.5 million kronor, or 2.79 kronor per share before dilution. Operating cash flow was 125.6 million kronor. The company said higher gross profit and scale helped margins even as it absorbed the ItWorks acquisition and had not yet realized full merger synergies. Peru launched as Zinzino's first official South American market in the first quarter. Zinzino also said board member Anna Frick resigned for personal reasons in April. The interim report was published under the EU Market Abuse Regulation. |
Zinzino Issues Shares to Settle Sanki and Bode Pro Acquisitions |
Press Release | 3/24/2026 Zinzino said it has issued 401,965 new B shares through a set-off of claims held by S&M Nano-Biotechnology S.A. de C.V. in connection with its acquisition of assets and subsidiaries of Mexico-based direct seller Sanki, announced in November 2025. The company also issued 69,621 B shares as payment related to its September 2025 acquisition of Bode Pro. Under the Sanki agreement, the acquisition was completed on January 1, 2026, for a fixed price of 8 million dollars, 7 million dollars of it in Zinzino shares and 1 million dollars in cash, plus up to 12 million dollars in performance-based earn-outs payable in shares. The deal included Sanki's subsidiaries in Colombia and Peru. Following the issues, Zinzino has 33,521,574 B shares and 38,634,966 shares in total outstanding, representing dilution of 1.22 percent. Zinzino launched its own operations in Peru in February and combined with It Works! in January. |
Zinzino Fourth-Quarter Revenue Jumps 45 Percent; Board Proposes 50 Percent Dividend Increase |
Press Release | 2/25/2026 GOTHENBURG, Sweden -- February 25, 2026 Zinzino reported fourth-quarter 2025 revenue of 1,035.3 million Swedish kronor, up 45 percent from 713.5 million kronor a year earlier, or 52 percent in local currencies. EBITDA rose to 175.2 million kronor, a margin of 16.9 percent compared with 10.2 percent, and net profit increased to 123.7 million kronor, or 3.41 kronor per share, from 43.2 million kronor. Operating cash flow was 271.5 million kronor. For the full year, revenue grew 51 percent to 3,337.5 million kronor, EBITDA reached 443.4 million kronor for a 13.3 percent margin, and net profit was 324.5 million kronor, or 9.09 kronor per share. During the fourth quarter Zinzino acquired a 35 percent stake in Xion, agreed to acquire the assets of Mexico-based direct seller Sanki and launched a Gut Health Test. The board proposed a dividend of 6.00 kronor per share, up 50 percent from 4.00 kronor, for approval at the annual general meeting on June 2, 2026. The company combined with U.S. direct seller It Works! in January. |
Zinzino Opens Peru as Next Latin American Market |
Press Release | 2/10/2026 Zinzino said it launched operations in Peru on February 10, 2026, expanding its presence in Latin America. The Swedish direct seller said Peru was already generating monthly sales of about 1.5 million Swedish kronor through its global web shop before the formal launch. "Peru is a natural next step in our Latin American growth," Chief Executive Dag Bergheim Pettersen said. The launch follows Zinzino's acquisition of assets of Mexico-based direct seller Sanki, which included subsidiaries in Colombia and Peru, and its combination with It Works! in January. "We see strong potential for our Peruvian Partners to build long-term success with our test-based concept," he said. The company said customer and partner support will be coordinated by its Latin American team together with a local country manager. Zinzino sells home health tests and nutritional supplements through independent partners in more than 100 markets. |
Zinzino Combines With It Works! in All-Share Deal |
Press Release | 1/26/2026 GOTHENBURG, Sweden -- January 26, 2026 Zinzino said it has signed and simultaneously closed an agreement to combine with U.S.-based direct sales company It Works! in an all-share transaction. Zinzino acquired the operating assets of the It Works! U.S. business, including inventory, distributor and customer agreements and intellectual property, as well as all shares of It Works! Marketing International UC, an Irish company, and its subsidiaries. The fixed purchase price of 30 million dollars was paid through a directed set-off issue of 1,843,840 new Zinzino B shares at 145.62 Swedish kronor per share, based on the volume-weighted average price over the two business days before the agreement. Additional consideration, estimated at 4 million dollars over five years, will also be paid in shares. Zinzino said the deal is expected to add more than 60 million dollars in revenue in 2026 and strengthen its distribution in North America and Europe. It Works!, whose founder and president is Mark Pentecost, sells health and wellness products through independent distributors. "Individual advice and tailor-made solutions are the future, and not just in health and wellness," Zinzino Chief Executive Dag Bergheim Pettersen and Pentecost said in a joint statement. |
Zinzino Third Quarter Revenue Jumps 47 Percent and Net Profit More Than Doubles on Acquisitions |
Press Release | 11/19/2025 GOTHENBURG, Sweden -- November 19, 2025 Zinzino reported third-quarter revenue of 784.1 million Swedish kronor, up 47 percent from 532.8 million kronor a year earlier and 53 percent in local currencies. Gross profit rose to 277.2 million kronor, a margin of 35.4 percent compared with 33.6 percent, and EBITDA increased to 109.7 million kronor from 63.0 million kronor, lifting the EBITDA margin to 14.0 percent from 11.8 percent. Net profit more than doubled to 89.4 million kronor from 42.6 million kronor, or 2.47 kronor per share compared with 1.24 kronor, and cash flow from operating activities was 136.6 million kronor. The company said the margin improvement came mainly from stronger gross profit and synergies, primarily from its acquisition of Zurvita, and that during the quarter it acquired the assets of U.S.-based direct sellers Bode Pro and Truvy to increase distribution in North America, Latin America, South Korea and Japan. For the first nine months, revenue rose 54 percent to 2,302.2 million kronor, EBITDA reached 268.2 million kronor and net profit was 200.9 million kronor. Cash and cash equivalents stood at 529.2 million kronor at September 30. After the quarter, Zinzino agreed to acquire Sanki, bought 35 percent of Xion International Group and launched a gut health test. |
Zinzino Completes Purchase of 35 Percent Stake in Algae Producer Xion, Plans Omega-3 Joint Venture |
Press Release | 11/11/2025 GOTHENBURG, Sweden -- November 11, 2025 Zinzino said it has acquired 35 percent of the shares in Andorra-based Xion International Group, completing the first step of a process it announced on July 11, 2025. Xion, a production company based in Spain with its own patents, has developed a high-tech photobioreactor system for producing spirulina microalgae and has annual turnover of about 1.3 million euros. Most of its current output goes into Zinzino's spirulina-based products, which were added through the 2024 acquisition of Xelliss. Zinzino paid a fixed purchase price of 1.2 million euros, consisting of 0.7 million euros in cash from its own reserves and 0.5 million euros in newly issued Zinzino B shares. The deal also gives Zinzino access to Xion's intellectual property rights. As the next step, the companies plan to form a specialized omega-3 company called PhytoFerm, 55 percent owned by Zinzino, to develop algae cultivation and secure a sustainable future supply of omega-3 for Zinzino's main product, BalanceOil+. "Fish oil is a finite resource," said Chief Executive Dag Bergheim Pettersen, adding that the partnership secures an important raw material without increasing the company's climate footprint. Xion founder Tino Bacchetta said PhytoFerm will combine photobioreactor and fermentation technologies. |
Zinzino to Acquire Mexican Direct Seller Sanki in Deal Worth Up to 20 Million Dollars |
Press Release | 11/8/2025 GOTHENBURG, Sweden -- November 8, 2025 Zinzino has signed an agreement with Mexico-based direct sales company Sanki to acquire the rights to its distributor database and associated customer register, inventory and intellectual property, as well as 100 percent of the shares in Sanki's subsidiaries in Colombia and Peru. Sanki, a health-focused direct seller operating in the United States, Mexico, Colombia and Peru, has total annual turnover of about 12 million dollars. Upon completion on January 1, 2026, Zinzino will pay a fixed purchase price of 8 million dollars, of which 7 million dollars will be settled in newly issued Zinzino shares and 1 million dollars in cash from its own reserves. Additional purchase payments of up to 12 million dollars, based on future sales, may be added and would be settled entirely in new shares. Zinzino said the deal will add distribution power and a trademarked product portfolio to be integrated into its test-based nutrition concept, and will accelerate its expansion in Peru and Colombia. The acquisition follows Zinzino's purchases of VMA Life in 2020, Enhanzz in 2022, Xelliss and ACN in 2024, and its 2025 asset acquisitions of Zurvita, Valentus, Ecosystem, Truvy and Bode Pro. Chief Executive Dag Bergheim Pettersen said that together with Sanki chief executive and co-founder Alejandro Lopez Tello, the companies bring many years of combined industry experience to drive a personalized shopping experience through direct sales. |
Zinzino Completes Acquisition of Truvy Assets and South Korean Subsidiary |
Press Release | 9/25/2025 GOTHENBURG, Sweden -- September 25, 2025 Zinzino said it has completed the acquisition of the distributor database, customer register, inventory and intellectual property rights of North American direct sales company Truvy, along with all of the shares in Truvy's South Korean subsidiary. Zinzino had announced a letter of intent to buy Truvy on September 5, 2025. Truvy sells health and weight loss products in North America, Latin America and South Korea and has annual turnover of about 12 million dollars. Zinzino will pay a fixed purchase price of 4 million dollars on completion, entirely in newly issued Zinzino shares, plus additional payments based on future sales that are estimated at 4 million dollars and could reach a maximum of 16 million dollars, also payable in new shares. Zinzino said acquiring the Korean subsidiary will speed its establishment in that country. The deal follows the company's 2025 asset acquisitions of Zurvita, Valentus, Ecosystem and Bode Pro. Zinzino Chief Executive Dag Bergheim Pettersen and Truvy Chief Executive and co-founder David Brown said the companies are now equipped to drive personalized shopping through direct sales. |
Zinzino Acquires Assets of Bode Pro to Expand in North America and Japan |
Press Release | 9/12/2025 GOTHENBURG, Sweden -- September 12, 2025 Zinzino has acquired the distributor database, customer register, inventory and intellectual property rights of U.S.-based direct sales company Bode Pro through an asset acquisition. Bode Pro sells health and wellness products primarily in North America and Japan and has annual turnover of about 7 million dollars, roughly 55 percent of it from Japan. Under the agreement, Zinzino will pay a fixed purchase price of 2 million dollars on completion, half in newly issued Zinzino shares, plus a deferred payment of 0.4 million dollars and additional payments tied to future sales of up to 3.6 million dollars, to be settled entirely in new shares. The cash portion will be paid from the company's own reserves. Zinzino said the deal will accelerate its expansion in Japan. The purchase follows Zinzino's 2025 asset acquisitions of Zurvita, Valentus and Ecosystem. Bode Pro founder and Chief Executive BK Boreyko said he is returning to his roots as a field leader with Zinzino. |
Zinzino Second Quarter Revenue Jumps 57 Percent to 794.4 Million Kronor on Acquisitions |
Press Release | 8/29/2025 GOTHENBURG, Sweden -- August 29, 2025 Zinzino reported second-quarter 2025 revenue of 794.4 million kronor, up 57 percent from 507.0 million kronor a year earlier, or 62 percent in local currencies. EBITDA rose to 79.7 million kronor from 63.0 million kronor, although the EBITDA margin narrowed to 10.0 percent from 12.4 percent and the gross margin fell to 31.2 percent from 34.4 percent. The Swedish direct seller said it acquired the assets of Valentus Global and Ecosystem SAS during the quarter to strengthen its distribution power in Europe. The Philippines achieved full market status and Zinzino launched in China with a locally adapted concept. First-half revenue rose 58 percent to 1.518 billion kronor and EBITDA rose to 158.4 million kronor from 114.7 million kronor. Cash flow from operating activities was 112.6 million kronor in the quarter, and cash and cash equivalents stood at 408.5 million kronor at the end of June. |
Zinzino Opens Talks to Buy 35 Percent of Algae Producer Xion to Secure Omega-3 Supply |
Press Release | 7/14/2025 GOTHENBURG, Sweden â€" July 14, 2025 Zinzino said it has started a process to acquire 35 percent of Xion International Group, an Andorra-based company with production in Spain that has developed a photobioreactor system for growing the microalgae spirulina. The two companies plan to form a joint venture, to be named PhytoFerm, to produce omega-3 and other oils from algae. The Swedish direct seller said the move is meant to secure a sustainable future supply of omega-3 for BalanceOil+, its main product, as global expansion and sales growth increase demand. Xion currently has turnover of about 1.3 million euros, and most of its output already goes into spirulina-based products Zinzino added through its 2024 acquisition of Xelliss. Co-ownership would also give Zinzino access to Xion's intellectual property. Zinzino said it aims to sign an agreement to acquire part of Xion's business in the second half of 2025. Chief Executive Dag Bergheim Pettersen said fish oil is a finite resource and that the venture would secure a vital raw material without increasing the company's carbon footprint. The deal would follow the company's asset acquisitions of Zurvita, Ecosystem and Valentus earlier in 2025. |
Zinzino First Quarter Revenue Jumps 59 Percent to 723.7 Million Kronor on Acquisitions |
Press Release | 5/20/2025 GOTHENBURG, Sweden, May 20, 2025 -- Zinzino reported first-quarter 2025 revenue of 723.7 million Swedish kronor, up 59 percent from 454.5 million kronor a year earlier and up 60 percent in local currencies. EBITDA rose to 78.8 million kronor from 51.7 million kronor, although the EBITDA margin slipped to 10.9 percent from 11.4 percent and gross margin narrowed to 30.9 percent from 35.4 percent. During the quarter the company completed the acquisition of the assets of Zurvita, including its distributor and customer database, strengthening its position in North America, and launched New Zealand as an official market. After the end of the quarter it acquired the assets of direct seller Valentus Global to add distribution power in Europe. Operating cash flow was 21.1 million kronor, compared with a negative 1.7 million kronor a year earlier. The board proposed a dividend of 4.00 kronor per share for 2024, up from 3.00 kronor, totaling 143.1 million kronor. Dag Bergheim Pettersen is chief executive. |
Zinzino Acquires Assets of Valentus Global to Expand Distribution in Europe |
Press Release | 4/11/2025 GOTHENBURG, Sweden, April 11, 2025 -- Zinzino said it has signed an asset purchase agreement to acquire the distributor database, customer records, inventory and intellectual property rights of Valentus Global, a Delaware-based direct selling company. Valentus had sales of more than 50 million Swedish kronor last year, mainly in Europe and North America. The purchase price is 20 million kronor payable at closing, of which about 10 million kronor relates to inventory. Zinzino said it will pay in cash from its own funds. The deal adds to a string of acquisitions by the Swedish supplement and skincare seller, including VMA Life in 2020, Enhanzz in 2022, Xelliss and ACN in 2024 and the assets of Zurvita earlier in 2025. The company said the acquisition is intended to increase its distribution power in Europe. |
Zinzino Launches Operations in New Zealand |
Press Release | 3/11/2025 GOTHENBURG, Sweden, March 11, 2025 -- Zinzino said it launched operations in New Zealand on March 11, 2025, as part of its plan to expand its customer base internationally, allowing its independent partners to build locally in the new market. The company said New Zealand's location in Oceania, advanced logistics and widespread use of social media as a business tool make it a hub for e-commerce, and it expects the launch to lift sales in New Zealand and surrounding regions. Customer and market support will be handled from its Gothenburg headquarters with help from local consultants. Zinzino said it now operates in well over 100 markets and maintained its goal of reaching 1 million customers in 2025 and 20 million by 2035. |
Zinzino Fourth Quarter Revenue Rises 35 Percent to 713.5 Million Kronor; Raises Dividend |
Press Release | 2/27/2025 GOTHENBURG, Sweden, February 27, 2025 -- Zinzino reported fourth-quarter 2024 revenue of 713.5 million Swedish kronor, up 35 percent from 527.9 million kronor a year earlier, or 37 percent in local currencies. EBITDA edged up to 72.9 million kronor, but the margin narrowed to 10.2 percent from 13.5 percent as gross margin fell to 30.6 percent from 38.3 percent. Operating cash flow rose to 179.8 million kronor. Full-year revenue grew 25 percent to 2.208 billion kronor, with EBITDA of 250.7 million kronor and an 11.4 percent margin. The company ended the year with 463.1 million kronor in cash. Zinzino said its debtor-in-possession financing of U.S.-based Zurvita's Chapter 11 case allowed it to complete the purchase of Zurvita's assets after year-end, strengthening its position in North America. The board proposed a dividend of 4.00 kronor per share for 2024, up from 3.00 kronor, after the company met and exceeded its financial targets. |
Zinzino Completes 9.4 Million Dollar Purchase of Bankrupt Zurvita's Assets |
Press Release | 2/14/2025 GOTHENBURG, Sweden, February 14, 2025 -- Zinzino said it finalized an agreement to acquire the assets of Zurvita, a U.S. direct-selling health and wellness company, after acting as debtor-in-possession lender in Zurvita's Chapter 11 case. Its offer was accepted as part of a debt-settled purchase following the restructuring. Zinzino will pay a fixed price of 9.4 million dollars, including the 4.5 million dollars of DIP financing it provided, with 2.5 million dollars settled in newly issued Zinzino shares and the cash portion funded from existing reserves. Earn-out payments tied to sales from 2025 to 2029 could add up to 1.9 million dollars, also payable in new shares. Zurvita operates in the United States, Canada and Mexico with annual sales of about 30 million dollars. Zinzino gains its distribution network, inventory and intellectual property and said it expects synergies from combining Zurvita with its test-based nutrition model and technology platform. |
Zinzino Provides 4.5 Million DIP Loan and Stalking-Horse Bid for Bankrupt Zurvita |
Press Release | 12/22/2024 GOTHENBURG, Sweden, December 22, 2024 -- Zinzino said it is providing 4.5 million dollars of debtor-in-possession financing to Zurvita Inc., a North American direct-selling health company that filed Chapter 11 on December 20, 2024, and is simultaneously making a stalking-horse offer to buy Zurvita's assets. If Zinzino's bid is accepted, the DIP loan would convert into part of a debt-settled purchase price after Zurvita runs a court-supervised sale process open to higher offers. If another bidder wins, Zinzino's loan would be repaid with certain process costs reimbursed. Zurvita generates about 30 million dollars of annual sales in the United States, Canada and Mexico. Chief Executive Dag Bergheim Pettersen said the deal fits Zinzino's acquisition strategy after VMA Life, Enhanzz, an ACN partnership and the Xelliss asset purchase. Zurvita Chief Executive Jay Shafer said Chapter 11 with Zinzino as financier offers the best path to continuity for staff and consultants after reviewing other options. |
Zinzino Third Quarter Revenue Jumps 22 Percent to 533 Million Kronor as Margins Compress |
Press Release | 11/19/2024 GOTHENBURG, Sweden, November 19, 2024 -- Zinzino reported third-quarter 2024 revenue of 532.8 million kronor, up 22 percent from 436.9 million kronor a year earlier, or 24 percent in local currencies. EBITDA fell to 63.0 million kronor from 71.2 million kronor, and the EBITDA margin narrowed to 11.8 percent from 16.3 percent on higher raw-material costs, normalized distributor compensation, acquisition-related sales costs and currency translation. The company said it expanded in France after strong sales growth tied to the Xelliss asset acquisition. After the quarter it launched Collagen Boozt and elevated the Canary Islands to full market status alongside mainland Spain. Nine-month revenue rose 21 percent to 1.49 billion kronor, with EBITDA of 177.8 million kronor and a margin of 11.9 percent. Cash and cash equivalents were 321.2 million kronor at September 30. |
Zinzino Second Quarter Revenue Jumps 24 Percent to 507 Million Kronor on Acquisitions and New Markets |
Press Release | 8/30/2024 GOTHENBURG, Sweden, Aug. 30, 2024 -- Zinzino reported second-quarter 2024 revenue of 507.0 million Swedish kronor, up 24 percent from 407.9 million kronor a year earlier. EBITDA rose to 63.0 million kronor from 53.7 million kronor, though the margin slipped to 12.4 percent from 13.2 percent, and net profit rose to 48.1 million kronor from 36.9 million kronor. During the quarter, Zinzino acquired the distributor database, inventory and intellectual property of Luxembourg-based Xelliss, bought 49 percent of Cypriot olive oil producer Cleanthi Alpha-Olenic and signed a letter of intent to acquire U.S. direct selling company Zurvita. It also announced a launch in Serbia. The company said the lower margin mainly reflected higher selling costs tied to acquisitions and new markets. Operating cash flow rose to 91.1 million kronor, and cash totaled 296.0 million kronor at June 30. Zinzino said it is on track toward about 2 billion kronor in revenue for full-year 2024. |
Zinzino First Quarter Sales Rise 15 Percent to 454.5 Million Kronor; EBITDA Margin Holds |
Press Release | 5/22/2024 GOTHENBURG, Sweden, May 22, 2024 -- Zinzino reported first-quarter 2024 revenue of 454.5 million kronor, up 15 percent from 393.7 million kronor a year earlier, with EBITDA of 51.7 million kronor and an EBITDA margin of 11.4 percent compared with 11.3 percent. Gross profit rose to 160.9 million kronor and the gross margin expanded to 35.4 percent from 33.2 percent. Cash and cash equivalents stood at 328.1 million kronor at quarter end. During the quarter Zinzino entered a European strategic partnership with North American direct seller ACN, which also invested 10.4 million kronor for 149,468 Zinzino B shares via a directed issue. After the period, Zinzino said it acquired rights to Luxembourg-based Xelliss SA's distributor database, inventory and intellectual-property assets for a fixed purchase price of 2 million euros, with contingent consideration of up to 8 million euros. Chief Executive Dag Bergheim Pettersen said the quarter left the company positioned for further growth. |
Zinzino Full-Year Sales Rise 22 Percent to 1.77 Billion Kronor; Raises Dividend and Partners With ACN |
Press Release | 2/27/2024 GOTHENBURG, Sweden, February 27, 2024 -- Zinzino reported full-year 2023 revenue of 1.766 billion Swedish kronor, up 22 percent from 1.443 billion kronor, with EBITDA of 240.6 million kronor and an EBITDA margin of 13.6 percent, up from 7.8 percent. Fourth-quarter revenue rose 23 percent to 527.9 million kronor, with EBITDA of 71.3 million kronor. The board proposed raising the dividend to 3.00 kronor per share from 1.75 kronor. After year end, Zinzino said it entered a strategic European partnership with North American direct selling company ACN, which also invested about 10.4 million kronor for 149,468 Zinzino B shares in a directed issue. Cash and cash equivalents were 321.2 million kronor at year end. Zinzino sells health and wellness products through a direct sales network and said sales-mix changes, efficiencies and scale helped lift margins. |
Zinzino Third Quarter Revenue Rises 25 Percent to 436.9 Million Kronor; EBITDA Nearly Triples |
Press Release | 11/16/2023 GOTHENBURG, Sweden, November 16, 2023 -- Zinzino AB reported third-quarter 2023 total revenue of 436.9 million kronor, up 25 percent from 349.9 million kronor a year earlier. EBITDA rose to 71.2 million kronor from 25.4 million kronor, lifting the EBITDA margin to 16.3 percent from 7.3 percent, and gross margin improved to 38.2 percent from 31.7 percent. Cash flow from operations was 104.4 million kronor. The company attributed the margin gains mainly to changes in sales mix, efficiencies and economies of scale. During the quarter Zinzino completed a sales launch in Mexico and its laboratory in Oslo analyzed its one millionth BalanceTest. For the first nine months, revenue rose 22 percent to 1,238.5 million kronor and EBITDA rose to 169.3 million kronor, with cash of 298.7 million kronor at September 30. The board maintained its forecast that 2023 would be a record year. Zinzino sells test-based nutrition and skincare products through independent partners in more than 100 markets. |
Zinzino Second Quarter Revenue Rises 24 Percent; Raises Full-Year Outlook |
Press Release | 8/31/2023 GOTHENBURG, Sweden, Aug. 31, 2023 -- Zinzino AB reported second-quarter 2023 total revenue of 407.9 million kronor, up 24 percent from 329.5 million kronor a year earlier. EBITDA rose to 53.7 million kronor from 20.1 million kronor, for a 13.2 percent margin compared with 6.1 percent. Gross profit margin was 36.4 percent versus 32.0 percent. Cash flow from current operations was 46.3 million kronor and cash and cash equivalents were 200.9 million kronor at midyear. On the back of first-half profitability, the company raised full-year 2023 revenue expectations to about 1,700 million kronor from a prior 1,500 million to 1,600 million kronor range, and raised the expected EBITDA margin to at least 9 percent from at least 7 percent. Zinzino is a Sweden-based direct seller of test-based personalized nutrition and skincare products listed on Nasdaq First North Premier Growth Market. |
Zinzino First Quarter Revenue Rises 18 Percent as EBITDA Margin Expands |
Press Release | 5/12/2023 GOTHENBURG, Sweden, May 12, 2023 -- Zinzino AB reported first-quarter 2023 total revenue of 393.7 million kronor, up 18 percent from 334.4 million kronor a year earlier. EBITDA rose to 44.4 million kronor from 25.8 million kronor, for an 11.3 percent margin compared with 7.7 percent. Gross profit margin was 33.2 percent versus 29.7 percent. Cash flow from current operations was 65.0 million kronor and cash and cash equivalents were 216.4 million kronor at quarter-end. During the quarter the company started sales in Turkey and launched new digital tools for distributors in Scandinavia. Zinzino is a Sweden-based direct seller of test-based personalized nutrition and skincare products listed on Nasdaq First North Premier Growth Market. |
Zinzino Full Year Revenue Rises 5 Percent as Fourth Quarter Profitability Improves |
Press Release | 2/28/2023 GOTHENBURG, Sweden, February 28, 2023 -- Zinzino AB reported fourth-quarter 2022 revenue of 429.3 million kronor, up 7 percent from 401.2 million kronor a year earlier. EBITDA rose to 40.8 million kronor from 26.4 million kronor, for a 9.5 percent margin compared with 6.6 percent. Full-year revenue was 1,443.1 million kronor, up 5 percent from 1,370.6 million kronor. Full-year EBITDA was 112.1 million kronor with a 7.8 percent margin, down from 10.0 percent a year earlier. Cash and cash equivalents were 161.9 million kronor at year-end. The board proposed a dividend of 1.75 kronor per share for 2022, down from 2.00 kronor the prior year, to the annual general meeting scheduled for May 31, 2023. Zinzino sells health products through a direct-selling model. |
Zinzino Third Quarter Revenue Rises 12 Percent as Margins Narrow |
Press Release | 11/17/2022 Zinzino AB reported third-quarter 2022 revenue of 349.9 million Swedish kronor, up 12 percent from 313.6 million kronor a year earlier. Gross margin narrowed to 31.7 percent from 34.3 percent. EBITDA fell to 25.4 million kronor, a 7.3 percent margin, from 40.4 million kronor, a 12.9 percent margin, and net profit declined to 14.3 million kronor from 28.2 million kronor. Nine-month revenue totaled 1,013.8 million kronor, up 5 percent, and cash stood at 163.7 million kronor. The company kept its full-year revenue expectation of about 1.4 billion kronor. During the quarter Zinzino launched the HANZZ+HEIDII skincare range acquired earlier in the year. The company said results were achieved despite sharply rising prices for raw materials and transport, shutdowns in the Asia Pacific region and the war in Ukraine. |
Zinzino Second Quarter Revenue Rises 2 Percent; Lowers Full-Year Outlook |
Press Release | 8/26/2022 Zinzino said second-quarter 2022 total revenue was 329.5 million kronor, up 2 percent from a year earlier. EBITDA was 20.1 million kronor with a 6.1 percent margin. The company lowered its full-year 2022 revenue outlook to about 1.4 billion kronor and its EBITDA-margin outlook to about 6 percent. Management pointed to uneven partner activity across European markets, currency effects, and cost inflation after earlier expansion and acquisition activity. Zinzino sells nutritional and skincare products through a direct-selling partner network with a focus on test-based wellness offerings. The company said it would continue investing in digital tools and partner training while tightening cost control. |
Zinzino First Quarter Revenue Holds Near Flat at 334.4 Million Kronor |
Press Release | 5/13/2022 Zinzino said first-quarter 2022 revenue was 334.4 million kronor, up 0.3 percent from a year earlier. EBITDA was 25.8 million kronor with a 7.7 percent margin. Operating cash flow was negative 8.9 million kronor, and cash and cash equivalents were 217.9 million kronor at quarter-end. Ireland and Belgium achieved full market status during the quarter, while the Russia establishment process was interrupted. After the quarter, Zinzino said it acquired Enhanzz IP AG and Enhanzz Global AG, including brand rights and a distributor organization. The company maintained 2022 targets for revenue above 1.5 billion kronor and an EBITDA margin above 7 percent, and kept a proposed dividend of 2 kronor per share. |
Zinzino Full Year Revenue Rises 20 Percent to 1.37 Billion Kronor |
Press Release | 2/28/2022 Zinzino said full-year 2021 total revenues rose 20 percent to 1,370.6 million Swedish kronor, with EBITDA of 137.6 million kronor and an EBITDA margin of 10.0 percent. Fourth-quarter revenues rose 18 percent to 401.2 million kronor, while EBITDA was 26.4 million kronor. The board proposed a dividend of 2.00 kronor per share, up from 1.25 kronor. The company said it launched Vitamin D Test and ZinoShine+ in the fourth quarter and started sales in South Africa on November 9 as its first African market. Cash flow from operating activities for the year was 153.5 million kronor, and liquid assets at year-end were 235.7 million kronor. Chief executive Dag Bergheim Pettersen presented the year-end report. |
Zinzino Third Quarter Revenue Rises 11 Percent and Lifts Profit Forecast |
Press Release | 11/19/2021 Zinzino reported third quarter group revenue of 313.6 million Swedish kronor, up 11 percent from 281.8 million kronor. Gross profit was 107.5 million kronor, a margin of 34.3 percent, up from 28.8 percent. EBITDA was 40.4 million kronor, up from 28.8 million kronor, and the EBITDA margin was 12.9 percent, up from 10.2 percent. Operating cash flow was 23.5 million kronor. The board raised the expected full-year EBITDA margin by one percentage point, to a range of 9 percent to 12 percent. It trimmed the revenue outlook and said full-year revenue should exceed 1,300 million kronor, compared with 1,139 million kronor in 2020, citing slower growth in the second half against a strong 2020 comparison. For the first nine months, revenue was 969.4 million kronor, up 21 percent, and cash was 182.9 million kronor. The report said Taiwan reached full market status during the quarter. Chief executive Dag Bergheim Pettersen was the disclosure contact. The interim report was released at 08:00 on November 19, 2021. |
Zinzino Launches Operations in South Africa |
Press Release | 11/9/2021 Zinzino said it launched its business in South Africa on November 9, 2021, its next step in a global expansion and its move onto the African continent. Sales director Kirsten Pearse called Africa a large unfinished opportunity for direct selling and said the company would bring its test-based nutrition model into the market. The company said years of preparation went into the opening and that it now operates in more than 100 markets. It repeated longer-term aims of 1 million customers by 2025 and 20 million by 2035. The release also recalled 2020 group sales of 1,139 million Swedish kronor, up 48 percent. Chief executive Dag Bergheim Pettersen and chief financial officer Fredrik Nielsen were listed as contacts. The announcement was published at 11:30 on November 9 under European disclosure rules. |
Zinzino Says Third Quarter Group Revenue Rose 11 Percent |
Press Release | 10/5/2021 Zinzino published a preliminary sales report showing group revenue for July through September of 312.9 million Swedish kronor, up 11 percent from 281.8 million kronor a year earlier. Revenue from Zinzino sales markets was 298.8 million kronor, also up 11 percent. External sales at Faun Pharma were 14.1 million kronor, up 10 percent. September alone brought group revenue of 117.8 million kronor, up 10 percent. For the first nine months, group revenue reached 968.7 million kronor, up 21 percent from 798.2 million kronor. Asia-Pacific third quarter revenue nearly doubled, while the Nordics declined. The company said the figures were released at 15:30 on October 5, 2021, under European market-abuse rules. The flash report covers sales by region and does not include profit. |
Zinzino Launches Full Operations in Taiwan |
Press Release | 9/9/2021 Zinzino said it launched its business in Taiwan on September 9, 2021 as the next step in a global expansion. Chief executive Dag Bergheim Pettersen said Taiwan is a mature direct-selling market and that the launch followed years of preparation and local adaptation. The company said Taiwan ranks tenth in the world by direct-selling sales, which made the opening a strategic one. With Taiwan, Zinzino said it would operate in close to 100 markets. It repeated a goal of 1 million customers by 2025 and 20 million by 2035. The release also noted 2020 sales of 1.139 billion Swedish kronor, up from 771 million kronor in 2019. Zinzino is listed in Sweden and is based in Gothenburg, with additional offices that now include Taiwan. The launch adds a local market rather than only cross-border sales. |
Zinzino Second Quarter Revenue Rises 18 Percent to 322.4 Million Kronor |
Press Release | 8/27/2021 Zinzino reported second-quarter total revenue of 322.4 million Swedish kronor, up 18 percent from 274.3 million kronor. EBITDA rose to 33.4 million kronor from 16.0 million kronor, and the EBITDA margin was 10.4 percent compared with 5.8 percent. Gross profit was 105.1 million kronor, a 32.6 percent margin, versus 73.5 million kronor and 26.8 percent a year earlier. Operating cash flow was 22.4 million kronor. The board raised the full-year EBITDA margin forecast to a range of 8 percent to 11 percent, from at least 6 percent. Full-year total income was expected to exceed 1,400 million kronor. For the first half, revenue rose 27 percent to 655.8 million kronor and EBITDA was 70.7 million kronor. Cash was 166.9 million kronor. Chief executive Dag Bergheim Pettersen presented the quarter as another period of sales growth with higher profitability from scale in systems, logistics, and the organization. The report said sales started in India during the quarter and that Malaysia reached full market status. New products BalanceOil+ Premium and ZinzinoGene+ were also introduced. |
Zinzino First Quarter Revenue Rises 38 Percent to 333.4 Million Kronor |
Press Release | 5/18/2021 Zinzino reported first-quarter group revenue of 333.4 million Swedish kronor, up 38 percent from 242.1 million kronor a year earlier. EBITDA was 37.3 million kronor, for a record margin of 11.2 percent. Adjusted EBITDA matched that result after prior-year accounting comparisons. Chief executive Dag Bergheim Pettersen said growth came in all regions except the Nordics, with the strongest gains in other European markets and also gains in Asia and North America. Gross profit was 101.2 million kronor. Cash flow from operating activities was 48.0 million kronor, and liquid assets ended at 191.5 million kronor. The company said scale in information technology, logistics, and organization improved margins. Zinzino markets test-based nutrition, skincare, and lifestyle products and is listed on Nasdaq First North Premier Growth Market. |